Clinical Handbook of Psychotropic Drugs for Children and Adolescents, 5th Edition

By Dean Elbe, Tyler R. Black, Ian R. McGrane, Sabina Choi

Ordering the Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a decision that can greatly benefit mental health professionals who work with young patients. This indispensable resource offers a comprehensive and up-to-date summary of psychotropic drugs specifically tailored to children and adolescents. With its easy-to-read comparison charts and tables, health professionals can quickly review treatment options and make informed decisions based on accurate information.

The handbook covers all classes of medication used in the treatment of young patients, providing concise and bulleted information on on-label and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and more. The inclusion of interaction and side effect comparison charts allows for a quick overview of different medications, helping health professionals weigh the benefits and potential risks of each drug.

The fifth edition of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents introduces new chapters and updates, ensuring that health professionals have access to the latest information. With new sections on prescribing safely and ethically, pharmacogenetics, aggression management, and more, this edition equips mental health professionals with the knowledge they need to provide the best care for their young patients.

In addition to its comprehensive content, the handbook stands out with its colorful design and recognizable icons, allowing for easy navigation and quick access to the desired information. The inclusion of patient and caregiver information sheets, available as printable PDF files, further enhances the usefulness of this resource.

Ordering the Clinical Handbook of Psychotropic Drugs for Children and Adolescents is not just a purchase, but an investment in the quality of care provided to young patients. With its accurate and up-to-date information, this book ensures that health professionals have the knowledge they need to make informed decisions and provide the best treatment options for children and adolescents.

Whether you are a psychiatrist, pediatrician, psychologist, physician, pharmacist, nurse, or other mental health professional, this handbook is an essential tool for your practice. Don’t miss out on the opportunity to have all the relevant information on psychotropic drugs at your fingertips. Order your copy of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents today and experience the benefits it can bring to your practice.

Product Details

• – Accurate and up-to-date
• – Specific to children and adolescents
• – Charts and tables help decision-making
• – Icons and full color

• • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
• • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more – all you need to know for each class of drug
• • Potential interactions and side effects summarized in comparison charts
• • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
• • Clearly written patient and caregiver information sheets for download as printable PDF files

• • New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents
• • Neuroscience-based nomenclature added to Product Availability tables
• • Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) completely revised plus new section on monitoring scales for EPSE
• • Anxiolytics section on buspirone and benzodiazepine comparison table revised
• • Mood Stabilizers chapter extensively revised
• • Natural Health Products comprehensively revised
• • New Unapproved Treatments revised, including preliminary evidence for cannabidiol and folinic acid for autism spectrum disorder and ketamine for mood disorder
• • New agents include: deutetrabenazine, ethopropazine, lemborexant, lumateperone, orphenadrine, tetrabenazine, valbenazine, viloxazine
• • New formulations and trade names include: Austedo, Caplyta, Dayvigo, Drizalma Sprinkle, Elepsia XR, Eprontia, Evekeo ODT, Gocovri, Hetlioz LQ, Ingrezza, Invega Hafyera, Jornay PM, Loreev XR, Lybalvi, Osmolex ER, Oxtellar XR, Parsitan, Perseris, Qelbree, Qudexy XR, Secuado, Spritam, Tyrvaya, Valtoco

• Publisher ‏ : ‎ HOGRE; 5th edition (May 8, 2023)
• Language ‏ : ‎ English
• Spiral-bound ‏ : ‎ 438 pages
• ISBN-10 ‏ : ‎ 0889376255
• ISBN-13 ‏ : ‎ 978-0889376250